Journal
CURRENT DIABETES REPORTS
Volume 8, Issue 2, Pages 107-113Publisher
CURRENT MEDICINE GROUP
DOI: 10.1007/s11892-008-0020-3
Keywords
-
Categories
Funding
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Ask authors/readers for more resources
The biology and properties of dendritic cells (DCs) have been intensely studied in the research areas of infectious diseases, tumor immunology, and vaccine development. This unique subset of immune cells has recently also moved to the center of interest for basic and clinical research in autoimmunity, owing not only to the extraordinary importance of DCs in the initiation and sustenance of adaptive immune responses, but also to more recent discoveries about their profound ability to control and downregulate ongoing T-cell responses. We review current progress of using DCs in mice for induction and propagation of autoimmune T-cell responses and their therapeutic potential to dampen or even stop beta-cell-specific autoimmunity. Finally, we offer our perspective on how basic research progress in DC technology, mostly from mouse models, may translate into emerging diagnostic and therapeutic applications for human type 1 diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available